Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000041

Chief Medical Officer sold 3,583 shares at $50.01 ($179,200)

  • Chief Medical Officer acquired 3,583 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bowden Christopher · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-20 Exercise or conversion : show line 1 in the form +3,583 $35.16 $125,978 11,889 D
2020-05-20 Sale : show line 2 in the form −3,583 $50.01 $179,200 8,306 D
Open-market sales · 3,583 sh · avg $50.01 · $179,200

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-20 Exercise or conversion : show line 3 in the form Stock option (right to buy) −3,583 15,723 D
Loading xslF345X03/wf-form4_159009512439488.xml…